CAS: 58-37-7; 1-N,1-N,2-N,2-N-Tetramethyl-3-Phenothiazin-10-Ylpropane-1,2-Diamine

上下游产品

CAS号92-84-2 吩噻嗪 | CAS号40550-12-7 2-chloro-N,N,N'...

10-[2,3-Bis(Dimethylamino)-Propyl]Phenothiazine Fumarate置于potassium Metaperiodate,磷酸,硫酸体系中,用 水 作为反应溶剂,化学反应生成 氨丙嗪
参考文献:Kuzmicka,L.; Puzanowska-Tarasiewicz,H.; Tarasiewicz,M.,Pharmazie,1988,Vol. 43,# 4,P. 288-289
标题:Kuzmicka,L.; Puzanowska-Tarasiewicz,H.; Tarasiewicz,M.,Pharmazie,1988,Vol. 43,# 4,P. 288-289

专利信息

专利号:US-7300639-B2
优先权日:2002-12-03
标 题:Process for removing metals from liquids
发明人：LIU WANSHENG
权利人:BRISTOL MYERS SQUIBB CO
摘要:A process is provided for removing one or more metals from liquids. Also provided is a process for the synthesis of aP2 inhibiting compounds having the formula (I) n nwherein R 1 , R 2 , R 3 , R 4 , HET, and X-Z are as described herein, which process comprising the step of removing one or more metals from a solution of the compound of formula I or an intermediate or precursor thereof. The processes for removing metal comprise the step of contacting the liquid with a solid extractant comprising a metal-binding functionality.

专利号:US-7993390-B2
优先权日:2002-02-08
标 题:Implantable or insertable medical device resistant to microbial growth and biofilm formation
发明人：MILLER KATHLEEN M; BUCAY-COUTO WEENNA; LI JIANMIN
权利人:BOSTON SCIENT SCIMED INC
摘要:Disclosed are implantable or insertable medical devices that provide resistance to microbial growth on and in the environment of the device and resistance to microbial adhesion and biofilm formation on the device. In particular, the invention discloses implantable or insertable medical devices that comprise at least one biocompatible matrix polymer region, an antimicrobial agent for providing resistance to microbial growth and/or a microbial adhesion/biofilm synthesis inhibitor for inhibiting the attachment of microbes and the synthesis and accumulation of biofilm on the surface of the medical device. Also disclosed are methods of manufacturing such devices under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of the biocompatible matrix polymer and substantially prevent chemical modification of said bioactive agents.